Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 48.31
+1.72 (3.69%)
Jul 15, 2026, 3:04 PM CST
Chengdu Kanghua Biological Products Company Description
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, and operation of biological products in China.
It offers freeze-dried human rabies vaccines; ACYW135 meningococcal polysaccharide vaccine. The company was founded in 2004 and is based in Chengdu, China.
Chengdu Kanghua Biological Products Co., Ltd.
| Country | China |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 550 |
| CEO | Hongbo Wu |
Contact Details
Address: No. 182, Beijing Road Chengdu, 610100 China | |
| Phone | 86 28 8484 6555 |
| Website | kangh.com |
Stock Details
| Ticker Symbol | 300841 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003Y57 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hongbo Wu | President and Non-Independent Director |
| Wennian Wu | Vice President, Chief Financial Officer, Secretary of the Board and Director |
| Huaigong Chen | Vice President and Quality Manager |
| Fu Wang | Vice President |
| Ping Liu | Accounting Supervisor |